In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...

The steep monthly costs of GLP-1 medications have long been a major obstacle for many patients trying to find effective ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

Eli Lilly cuts cash prices for Zepbound weight-loss vials on LillyDirect, offering doses from $299 to $449 as demand for ...

Over the last few years, the interest in GLP-1 drugs for weight loss has skyrocketed. Currently, the most common delivery system for GLP-1 medications is through pre-filled injection pens designed to ...

The success of semaglutide and tirzepatide is evident in their 2024 sales volumes and revenues, creating a clearer picture of ...

I don’t feel like I’m dragging anymore.” So far, he has experienced no side effects and plans to continue microdosing as long ...

Future Market Insights (FMI) today announced new findings from its latest flagship report on the GLP-1 Receptor Agonist ...

Next-generation pills and monthly injectables promise more choice, fewer side effects and broader health benefits.

Lilly's Zepbound price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's LillyDirect website.

The announcement came just weeks after rival Novo Nordisk cut prices for cash buyers of its top-selling weight loss drugs ...